Scilex Holding Company, A Sorrento Company And Vickers Vantage Corp. I Announce Effectiveness Of Registration Statement On Form S-4, Date Of Vickers Vantage Extraordinary General Meeting To Approve Proposed Business Combination

Author: Benzinga Newsdesk | October 31, 2022 09:03am

• SEC declared Effectiveness of Vickers's registration statement on Form S-4
• Extraordinary General Meeting of Vickers Vantage Corp. I shareholders to approve the proposed Business Combination is scheduled to be held on November 9, 2022, at 10:00 a.m., Eastern Time
• Post-closing company will be renamed "Scilex Holding Company" upon closing of the Business Combination, with common stock and warrants expected to trade on the Nasdaq Capital Market under the new ticker symbols "SCLX" and "SCLXW", respectively.
• Closing of Business Combination can provide up to approximately $100 million of gross cash proceeds in the trust (assuming no redemptions by Vickers Vantage shareholders and before expenses associated with the transaction)

PALO ALTO and NEW YORK, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex"), a Sorrento Company (nearly 100% or over 99.9% majority-owned subsidiary of Sorrento Therapeutics, Inc.) (NASDAQ:SRNE, ", Sorrento", ))))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and Vickers Vantage Corp. I (NASDAQ:VCKA, ", , Vickers", , ))))), a special purpose acquisition company, today announced that Vickers's registration statement on Form S-4 (the "Registration Statement") related to the previously announced proposed business combination between Vickers and Scilex (the "Business Combination") has been declared effective by the U.S. Securities and Exchange Commission (the "SEC").

Vickers will hold an extraordinary general meeting of shareholders (the "Meeting") at 10:00 a.m., Eastern Time on November 9, 2022 to approve, among other things, the proposed Business Combination. Shareholders of record of Vickers at the close of business on October 20, 2022 will be entitled to receive notice of and to vote at the Meeting. The Meeting will be held at 10:00 a.m., Eastern time, on Wednesday, November 9, 2022 at the Nasdaq World Headquarters located at 151 W. 42nd St., 10FL Einstein Executive Conference Room, New York, NY 10036, United States of America, and virtually via live webcast at www.cstproxy.com/​vickersvantagecorpi/sm2022. The Business Combination is expected to close shortly after approval by Vickers's and Scilex's shareholders and the satisfaction of other customary closing conditions as described in the Registration Statement.   

Upon the closing of the Business Combination, the combined company is expected to be listed for trading on the Nasdaq Capital Market with its common stock trading under the new ticker symbol "SCLX" and its warrants trading under the new ticker symbol "SCLXW".

Investors and security holders will be able to obtain free copies of the Registration Statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC by Vickers through the website maintained by the SEC. www.sec.gov/Archives/edgar/data/1820190/000110465922112557/tm2214659-30_424b3.htm

Posted In: SRNE VCKA